Clinical Trial Update: Safety and Efficacy of Two Doses of SP-8203 in Patients With Ischemic Stroke Requiring rtPA [Phase 2]

View source ↗

Summary

Phase 2 trial update on SP-8203 for ischemic stroke patients needing rtPA, reporting safety and efficacy results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Stroke

Drugs mentioned

• SP-8203

Snippet

Sponsor: Shin Poong Pharmaceutical Co. Ltd. | Conditions: Ischemic Stroke | Phase 2 | Status: COMPLETED